Press Releases

    • March 4, 2021

    Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy

    Loughborough, England, March 04, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    March 3, 2021

    Nemaura Medical to Present at the H.C. Wainwright Global Life Sciences Conference

    Loughborough, England – March 3, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    February 5, 2021

    Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing

    Loughborough, England – February 4, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    February 1, 2021

    Nemaura Medical Appoints Jay L. Warner as Head of U.S. Commercial Operations

    Loughborough, England – February 1, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    December 17, 2020

    Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT™ Non-Invasive, Daily-Wear Adhesive Glucose Monitor

    Loughborough, England – December 17, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    November 17, 2020

    Nemaura Medical Launches BEAT™diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website

    Loughborough, England – November 17, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    November 16, 2020

    Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update

    Loughborough, England – November 16, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    October 22, 2020

    Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020

    Loughborough, England – October 22, 2020 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    September 21, 2020

    Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products

    Clinically proven app from Healthimation LLC, to be paired with Company’s proBEAT™ non-invasive CGM system solution to offer convenient...

    Read more
    September 18, 2020

    Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer

    Loughborough, England – September 18 , 2020 (BusinessWire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical...

    Read more